| ADI-905-305-100 | 100 µg | 493.00 USD |  |
||
| Do you need bulk/larger quantities? | |||||
| Alternative Name: | BlySR3, TNFRSF 13C, CD268 |
| Host: | Rabbit |
| Immunogen: | Synthetic peptide corresponding to the sequence near the C-terminus of human BAFF receptor. |
| UniProt ID: | Q96RJ3 |
| Species reactivity: | Human, Mouse, Rat |
| Applications: | IHC, WB |
| Recommended Dilutions/Conditions: | Immunohistochemistry (5µg/ml) Western Blot (2-5µg/ml) Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
| Purity Detail: | Peptide affinity purified. |
| Formulation: | Liquid. In PBS containing 0.02% sodium azide. |
| Shipping: | Blue Ice |
| Long Term Storage: | -20°C |
| Scientific Background: | BAFF, or B-cell Activating Factor, is a member of the TNF superfamily also known as BLyS (B Lymphocyte Stimulator), TALL-1 (TNF- and ApoLrelated Leukocyte-expressed Ligand), and THANK (TNF Homologue that Activate Apoptosis, NF-κB and c-jun N-terminal Kinase). BAFF/BLyS was characterized as a B-cell activator since it induced B-cell proliferation and immunoglobulin secretion. Three receptors for BAFF were identified and designated TACI, BCMA, and BAFF-R. BAFF and its receptors are essential for B-cell development, survival, and humoral immune responses. |
| Regulatory Status: | RUO - Research Use Only |
